SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-17-361673
Filing Date
2017-12-05
Accepted
2017-12-05 16:45:04
Documents
6
Period of Report
2017-12-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d444924d8ka.htm 8-K/A 20228
2 EX-23.1 d444924dex231.htm EX-23.1 1879
3 EX-99.1 d444924dex991.htm EX-99.1 537581
4 EX-99.2 d444924dex992.htm EX-99.2 315929
5 EX-99.3 d444924dex993.htm EX-99.3 182608
6 EX-99.4 d444924dex994.htm EX-99.4 194269
  Complete submission text file 0001193125-17-361673.txt   1253761
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35405 | Film No.: 171240220
SIC: 2834 Pharmaceutical Preparations